These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27162583)

  • 1. Neuroendocrine hormone amylin in diabetes.
    Zhang XX; Pan YH; Huang YM; Zhao HL
    World J Diabetes; 2016 May; 7(9):189-97. PubMed ID: 27162583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Amylin: From Pathology to Physiology and Pharmacology.
    Ling W; Huang YM; Qiao YC; Zhang XX; Zhao HL
    Curr Protein Pept Sci; 2019; 20(9):944-957. PubMed ID: 30919775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspects of secretion and actions of amylin: interplay between amylin and other hormones.
    Schmitz O; Nyholm B; Juhl CB; Lund S; Orskov L
    J Endocrinol Invest; 1999; 22(5 Suppl):33-6. PubMed ID: 10442568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity.
    Kiriyama Y; Nochi H
    Cells; 2018 Aug; 7(8):. PubMed ID: 30082607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amylin: history and overview.
    Ludvik B; Kautzky-Willer A; Prager R; Thomaseth K; Pacini G
    Diabet Med; 1997 Jun; 14 Suppl 2():S9-13. PubMed ID: 9212323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of amylin in nutrient intake - animal studies.
    Young A
    Diabet Med; 1997 Jun; 14 Suppl 2():S14-8. PubMed ID: 9212324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amylin/IAPP (islet amyloid polypeptide)--physiology and clinical significance].
    Ludvik B
    Wien Klin Wochenschr; 1997 Jun; 109(11):379-83. PubMed ID: 9281227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control.
    Weyer C; Maggs DG; Young AA; Kolterman OG
    Curr Pharm Des; 2001 Sep; 7(14):1353-73. PubMed ID: 11472273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents.
    Moore CX; Cooper GJ
    Biochem Biophys Res Commun; 1991 Aug; 179(1):1-9. PubMed ID: 1679326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus.
    Nyholm B; Brock B; Ørskov L; Schmitz O
    Expert Opin Investig Drugs; 2001 Sep; 10(9):1641-52. PubMed ID: 11772274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural effects driven by rare point mutations in amylin hormone, the type II diabetes-associated peptide.
    Mendes WS; Franco OL; Alencar SA; Porto WF
    Biochim Biophys Acta Gen Subj; 2021 Aug; 1865(8):129935. PubMed ID: 34044067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular insights into the oligomerization dynamics and conformations of amyloidogenic and non-amyloidogenic amylin from discrete molecular dynamics simulations.
    Wang Y; Liu Y; Zhang Y; Wei G; Ding F; Sun Y
    Phys Chem Chem Phys; 2022 Sep; 24(36):21773-21785. PubMed ID: 36098068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing diabetes treatment using an amylin analogue.
    Edelman SV
    Diabetes Educ; 2008; 34 Suppl 1():4S-10S. PubMed ID: 18268000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of amylin in diabetes and in regulation of nutrient load.
    Young A; Denaro M
    Nutrition; 1998 Jun; 14(6):524-7. PubMed ID: 9646295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin.
    Sakagashira S; Hiddinga HJ; Tateishi K; Sanke T; Hanabusa T; Nanjo K; Eberhardt NL
    Am J Pathol; 2000 Dec; 157(6):2101-9. PubMed ID: 11106582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amylin in the periphery.
    Wookey PJ; Xuereb L; Tikellis C; Cooper ME
    ScientificWorldJournal; 2003 Mar; 3():163-75. PubMed ID: 12806128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of feline diabetes mellitus.
    Lutz TA; Rand JS
    Vet Clin North Am Small Anim Pract; 1995 May; 25(3):527-52. PubMed ID: 7660530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of amylin on the release of insulin and glucagon from the perfused rat pancreas.
    Inoue K; Hiramatsu S; Hisatomi A; Umeda F; Nawata H
    Horm Metab Res; 1993 Mar; 25(3):135-7. PubMed ID: 8477949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?
    Asmar M; Bache M; Knop FK; Madsbad S; Holst JJ
    J Clin Endocrinol Metab; 2010 May; 95(5):2367-75. PubMed ID: 20194711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.